120 related articles for article (PubMed ID: 134535)
1. [Experiences with DNCB sensitization in normal human individuals of various age groups (author's transl)].
Bürkle PA; Tönnesmann E; Ahnefeld S; Nobbe F; Federlin K
Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(2):153-65. PubMed ID: 134535
[TBL] [Abstract][Full Text] [Related]
2. Immunological studies in psoriasis. The quantitative evaluation of cell-mediated immunity in patients with psoriasis by experimental sensitization to 2,4-dinitrochlorobenzene.
Obalek S; Haftek M; Sliński W
Dermatologica; 1977; 155(1):13-25. PubMed ID: 303184
[TBL] [Abstract][Full Text] [Related]
3. [DNCB contact sensitization: theoretical and clinical aspects (author's transl)].
Tönnesmann E; Bürkle PA; Federlin K
Immun Infekt; 1977 Dec; 5(6):227-40. PubMed ID: 338472
[TBL] [Abstract][Full Text] [Related]
4. Dinitrochlorobenzene contact sensitization in pulmonary tuberculosis.
Malaviya AN; Sehgal KL; Kumar R; Dingley HB
Clin Exp Immunol; 1975 Dec; 22(3):399-403. PubMed ID: 1225485
[TBL] [Abstract][Full Text] [Related]
5. [Importance of the correlation of the DNCB and T lymphocyte test in the evaluation of cellular immunity in various forms of glomerulonephritis].
Redzepagić B; Tomasević M; Zildzić V
Med Pregl; 1983; 36(9-10):401-4. PubMed ID: 6609301
[No Abstract] [Full Text] [Related]
6. [Examination of immunologic reaction of the cellular type using the DNCB test in patients with bone tumors (author's transl)].
Lipenský R; Urban K
Acta Chir Orthop Traumatol Cech; 1979 Dec; 46(6):485-90. PubMed ID: 532518
[No Abstract] [Full Text] [Related]
7. Sequential evaluation of DNCB reactivity in patients with primary lung cancer. Correlation with prognosis.
Inoue H; Ishihara T; Kobayashi K; Fukai S
J Thorac Cardiovasc Surg; 1978 Oct; 76(4):479-82. PubMed ID: 703354
[TBL] [Abstract][Full Text] [Related]
8. Dinitrochlorobenzene contact sensitization in patients with end-stage renal disease.
Waltzer WC; Gonder MJ
Allergol Immunopathol (Madr); 1984; 12(6):479-82. PubMed ID: 6335629
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte transformation during dinitrochlorobenzene contact sensitization. An in vitro and in vivo evaluation of the primary immune response in man.
Miller AE; Levis WR
J Clin Invest; 1973 Aug; 52(8):1925-30. PubMed ID: 4719669
[TBL] [Abstract][Full Text] [Related]
10. Quantitation of cell-mediated immunity: responses to dinitrochlorobenzene and ubiquitous antigens.
Thompson CD; Whittingham S; Mackay IR; Khoo SK; Toh BH; Stagg RJ
Can Med Assoc J; 1975 May; 112(9):1078-81. PubMed ID: 1079163
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of sensitization and responsiveness to dinitrochlorobenzene in normal subjects.
Friedmann PS; Moss C; Shuster S; Simpson JM
Br J Dermatol; 1983 Jul; 109 Suppl 25():86-8. PubMed ID: 6860585
[TBL] [Abstract][Full Text] [Related]
12. Secondary immunodeficiency in miliary tuberculosis.
Uberoi S; Malaviya AN; Chattopadhyay C; Kumar R; Shrinivas
Clin Exp Immunol; 1975 Dec; 22(3):404-8. PubMed ID: 1083782
[TBL] [Abstract][Full Text] [Related]
13. Antigen-binding T and B lymphocytes in sensitization and unresponsiveness to dinitrochlorobenzene (DNCB) contact sensitivity.
Polak L; Rydén A; Roelants GE
Immunology; 1975 Mar; 28(3):479-84. PubMed ID: 1079198
[TBL] [Abstract][Full Text] [Related]
14. Influence of topical exposure to chemical allergens on murine Langerhans cells. Comparison of 2,4-dinitrochlorobenzene with trimellitic anhydride.
Cumberbatch M; Gould SJ; Peters SW; Basketter DA; Dearman RJ; Kimber I
J Clin Lab Immunol; 1992; 37(2):65-81. PubMed ID: 1340505
[TBL] [Abstract][Full Text] [Related]
15. [Epidermal reactivity of DNP (dinitrophenyl) compounds following epidermal DNCB (2,4-dinitrochlorobenzene) sensitization].
Lübbe D; Schwartze G; Wozniak KD
Dermatol Monatsschr; 1984; 170(6):395-403. PubMed ID: 6468710
[No Abstract] [Full Text] [Related]
16. Diminished contact sensitivity response in vitiliginous skin.
Uehara M; Miyauchi H; Tanaka S
Arch Dermatol; 1984 Feb; 120(2):195-8. PubMed ID: 6696471
[TBL] [Abstract][Full Text] [Related]
17. Hapten-specific lymphocyte transformation in humans sensitized with NDMA or DNCB.
SoebergB ; Andersen V
Clin Exp Immunol; 1976 Sep; 25(3):490-2. PubMed ID: 963911
[TBL] [Abstract][Full Text] [Related]
18. Tests of cell mediated immunity in patients with early breast cancer. I. Response to DNCB at time of mastectomy.
Davies CJ; Meredith ID; Robins RA; Blamey RW; Baldwin RW
Clin Oncol; 1978 Sep; 4(3):227-34. PubMed ID: 750125
[No Abstract] [Full Text] [Related]
19. [Study of the DNCB skin test in patients with solid neoplasms].
Mor C; Marcovina S; Moro E; Radice F; Russo R; Trinca E
Arch Sci Med (Torino); 1978; 135(3):377-82. PubMed ID: 708088
[TBL] [Abstract][Full Text] [Related]
20. Specific blastogenesis and lymphokine production in DNCB-sensitive human leucocyte cultures stimulated with soluble and particulate DNP-containing antigens.
Levis WR; Whalen JJ; Powell JA
Clin Exp Immunol; 1976 Mar; 23(3):481-90. PubMed ID: 947646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
